Incontinentia pigmenti

[MIM 308300]

(Bloch-Sulzberger Syndrome, Bloch-Siemens syndrome)

Prevalence: around 0,7/100 000. Sporadic cases or X-linked dominant transmission of a mutation of the NEMO gene, nowadays known as IKBKG (NF-κB essential modulator) (Xq28). Rare multisystemic ectodermal dysplasia usually lethal in  boys, except in case of 47 XXY. Characterized by a combination of cutaneous manifestations of neonatal onset and resulting in hyperpigmentation before 1 year of age.

 

The dermatosis evolves into 4 stages: 


1)         erythematobullous (first weeks): vesicobullous erythema, following the Blashko lines on the limbs, swirled on the scalp; 



2)         verrucholichenoid (2 to 8 weeks of age): hypertrophic, warty or lichenoid lesions. 

3)         pigmentary (from 6 to 12 months of age until aduldhood): special layout (swirls, water jets) or linear, better seen under Wood's light 

4)         involutive (aduldhood): disappearance of pigmented plaques and appearance of achromic zones. 
Alopecia and nail dysplasia can also be present.


There are extracutaneous lesions in 50-80 % of cases:


-         eyes (35 %): corneal opacities, cataract, uveitis, nystagmus, retinal detachment, optic atrophy

-         central nervous system (30 %): pyramidal syndrome, cerebellar ataxia, mental retardation, epilepsy (30 %), cerebral vascular accidents

-         teeth: partial anodontia, caries, high-arched palate, sometimes cleft palate

-         rare: heart disease, a few cases of rapidly fatal pulmonary hypertension, facial hemiatrophy


There is a predisposition to retinoblastoma, nephroblastoma and myeloid leukemia.


Anesthetic implications: 

eye protection.  Fragile skin in the areas involved by the dermatosis.: avoid any adhesive dressing and prefer silicone dressings. Difficult peripheral venous access. Specific anesthesia of an epileptic child; echocardiography. Risk of difficult intubation (teeth). Corticotherapy.


References:

-        Yasuda K, Minami N, Yoshikawa Y, Taketani T et al.
Fatal pulmonary arterial hypertension in an infant girl with incontinentia pigmenti.
Pediatr Internat 2016; 58 : 394-7

-        Batson R, Keeling BH, Diaz LZ.
Incontinentia pigmenti.
J Pediatr 2016; 176: 218.

-        Atallah V, Meot M, Kossorotoff M, Galmiche-Rolland L et al.
A case of reversible pulmonary hypertension associaed with incontinentia pigmenti.
Pulm Circulation 2018; doi : 10.1177/2045894018793983

-        Sugur T, Kavakli AS,Metiyurt HF.
Anaesthesia and orphan disease :a child with incontinentia pigmenti.
Eur J Anaesthesiol 2020 ; 37 : 141-3

-        Glade DC, Sitabkhan AZ, Osswald SS.
Spreading vesicles in a neonate.
J Pediatr 2020 ; 219 ; 275-6.

-        Baig SM, Shah SP.
The anesthetic challenges of caring for a pediatric patient with incontinentia pigmenti.
A&A Practice 2021; 15:e01384


Updated: February 2021